Ignite Creation Date:
2024-05-06 @ 2:14 PM
Last Modification Date:
2024-10-26 @ 1:27 PM
Study NCT ID:
NCT04256941
Status:
COMPLETED
Last Update Posted:
2024-04-16
First Post:
2020-01-21
Brief Title:
Aromatase Inhibitor Therapy With or Without Fulvestrant for the Treatment of HR Positive Metastatic Breast Cancer With an ERS1 Activating Mutation the INTERACT Study
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Anatomic Stage IV Breast Cancer AJCC v8 |
| Metastatic Breast Carcinoma |
| Prognostic Stage IV Breast Cancer AJCC v8 |
Keywords: